Heparanase, which is overexpressed in PC, acts by cleaving heparan sulfate side chains from proteoglycans, contributing to ECM disruption and vascular endothelial growth factor A (VEGF-A) and fibroblast growth factor 2 (FGF-2) release [51]. Here, VEGFA is linked to pachyonychia congenita.